Chapter 15 Epistemic Gains and Epistemic Games
Reliability and Higher Order Evidence in Medicine and Pharmacology
dc.contributor.author | Osimani, Barbara | |
dc.date.accessioned | 2021-08-04T10:11:41Z | |
dc.date.available | 2021-08-04T10:11:41Z | |
dc.date.issued | 2020 | |
dc.identifier.uri | https://library.oapen.org/handle/20.500.12657/50312 | |
dc.description.abstract | In this paper I analyse the dissent around evidence standards in medicine and pharmacology as a result of distinct ways to address epistemic losses in our game with nature and the scientific ecosystem: an “elitist” and a “pluralist” approach. The former is focused on reliability as minimisation of random and systematic error, and is grounded on a categorical approach to causal assessment, whereas the latter is more focused on the high context-sensitivity of causation in medicine and in the soft sciences in general, and favours probabilistic approaches to scientific inference, as better equipped for defeasibility of causal inference in such domains. I then present a system for probabilistic causal assessment from heterogenous evidence that makes justice of concerns from both positions, while also incorporating “higher order evidence” (evidence/information about the evidence itself) in hypothesis confirmation. | en_US |
dc.language | English | en_US |
dc.subject.classification | thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology | en_US |
dc.subject.other | Uncertainty Management in Pharmacology, Causality,Medical Epistemology, evidence standards, random error, systematic error, extrapolation, relevance, bias | en_US |
dc.title | Chapter 15 Epistemic Gains and Epistemic Games | en_US |
dc.title.alternative | Reliability and Higher Order Evidence in Medicine and Pharmacology | en_US |
dc.type | chapter | |
oapen.identifier.doi | 10.1007/978-3-030-29179-2_15 | en_US |
oapen.relation.isPublishedBy | 6c6992af-b843-4f46-859c-f6e9998e40d5 | en_US |
oapen.relation.isPartOfBook | 6dde7ba1-8654-4ccc-9249-6bef6c837290 | en_US |
oapen.relation.isFundedBy | 178e65b9-dd53-4922-b85c-0aaa74fce079 | en_US |
oapen.relation.isbn | 9783030291785 | en_US |
oapen.collection | European Research Council (ERC) | en_US |
oapen.pages | 28 | en_US |
oapen.grant.number | 639276 | |
oapen.grant.project | PhilPharm |